Saving Lives
We are Proven
Drug Developers
We are pioneers. We wrote the book on Targeted Protein Degradation with the development of the IMiDs, one of the most successful anti-cancer franchises in history. We have brought this unmatched expertise to bear at BioTheryX in the development of novel therapeutics for oncology and inflammatory diseases.
We Treat Diseases
with Protein Degradation
Our technology uses Targeted Protein Degradation with our novel, small molecule PHM® ‘molecular glues’, that regulate protein equilibrium. PHMs have potential applicability to a very broad range of disease targets, including those that have to date been considered undruggable.
Our initial programs are focused on protein degradation and multi-kinase inhibition to treat serious cancers AML and MDS.
We Treat Diseases
with Protein Degradation
Our technology uses Targeted Protein Degradation with our novel, small molecule PHM® ‘molecular glues’, that regulate protein equilibrium. PHMs have potential applicability to a very broad range of disease targets, including those that have to date been considered undruggable.
Our initial programs are focused on protein degradation and multi-kinase inhibition to treat serious cancers AML and MDS.
